Search
for
Sort by
Research 841–870 of 1000+
- A randomized, double-blind, placebo controlled, and half-head study to evaluate the effects of platelet-rich plasma on androgenetic alopecia
- An umbrella review of the use of platelet‐rich plasma in the treatment of androgenetic alopecia
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Epidermal Development in Mammals: Key Regulators, Signals from Beneath, and Stem Cells
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Hair: What is New in Diagnosis and Management?
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Novel and Established Potassium Channel Openers Stimulate Hair Growth In Vitro: Implications for their Modes of Action in Hair Follicles
- Platelet-rich plasma—an ‘Elixir’ for treatment of alopecia: personal experience on 117 patients with review of literature
- A Retrospective Study on the Use of Dermis Micrografts in Platelet-Rich Fibrin for the Resurfacing of Massive and Chronic Full-Thickness Burns
- Platelet-Rich Plasma (PRP) and Adipose-Derived Stem Cell (ADSC) Therapy in the Treatment of Genital Lichen Sclerosus: A Comprehensive Review
- Review of Human Hair Follicle Biology: Dynamics of Niches and Stem Cell Regulation for Possible Therapeutic Hair Stimulation for Plastic Surgeons
- Conventional and novel stem cell based therapies for androgenic alopecia
- Androgenetic alopecia; drug safety and therapeutic strategies
- A proposal of an effective platelet-rich plasma protocol for the treatment of androgenetic alopecia
- Review of factors affecting the growth and survival of follicular grafts.
- Estudio transversal acerca de los hábitos de prescripción en alopecia androgénica de los dermatólogos en España en 2017
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- The Tumor Necrosis Factor-α Level in Platelet-Rich Plasma Might Be Associated with Treatment Outcome in Patients with Interstitial Cystitis/Bladder Pain Syndrome or Recurrent Urinary Tract Infection
- Physiology and Medical Treatments for Alopecia
- Platelet-rich Plasma for Androgenetic Alopecia Treatment: A Randomized Placebo-controlled Pilot Study
- Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study
- New Treatments for Hair Loss
- Safety and efficacy of platelet-rich plasma injection for treatment of erectile dysfunction: a prospective randomized controlled study
- Platelet factor 4 inhibits human hair follicle growth and promotes androgen receptor expression in human dermal papilla cells
- Ottawa, Ontario, Canada, February 13–16, 2013